You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adenocarcinoma, Follicular

Showing 1 - 25 of 2,872
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hürthle Cell Carcinoma and Follicular Thyroid Carcinoma

Completed
  • Huerthle Cell Carcinoma
    • (no location specified)
    Jul 20, 2023

    Pathological Manifestation in Thyroid Follicular Neoplasm: Early

    Not yet recruiting
    • Thyroid Cancer
    • Follicular Thyroid Cancer
      • (no location specified)
      Jul 20, 2022

      Studies on Tumors of the Thyroid

      Recruiting
      • Hurthle Cell Thyroid Cancer
      • +4 more
      • 68-Gallium Dotatate
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 26, 2023

      Thyroglobulin and Galectin-3 for Prognosis and Follow-up in

      Recruiting
      • Thyroid Cancer
      • +2 more
        • Taipei, Taiwan
          Chih-Yuan Wang, M.D
        Oct 16, 2022

        Radioiodine Planar andSPECT/CT Imaging With Iodine-123 for

        Recruiting
        • Thyroid Gland Follicular Carcinoma
        • Computed Tomography
        • +3 more
        • Rochester, Minnesota
          Mayo Clinic in Rochester
        Jan 4, 2023

        Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

        Not yet recruiting
        • Thyroid Cancer
        • +5 more
        • Boston, Massachusetts
          Massachusetts General Hospital
        Dec 20, 2022

        Aberrant Helix Pomatia Agglutinin Binding Glycan Expression in

        Completed
        • Follicular Thyroid Cancer
        • Lectin-histochemistry retrospectively performed
        • Singapore, Singapore
          National University Hospital
        Sep 25, 2021

        18F-TFB PET/CT Scan in Differentiated Thyroid Cancer

        Recruiting
        • Differentiated Thyroid Gland Carcinoma
        • +2 more
        • Computed Tomography
        • +3 more
        • Rochester, Minnesota
          Mayo Clinic in Rochester
        Jan 4, 2023

        Refractory Thyroid Gland Carcinoma, Refractory Thyroid Gland Papillary Carcinoma, Refractory Thyroid Gland Follicular Carcinoma

        Recruiting
        • Refractory Thyroid Gland Carcinoma
        • +3 more
        • 177Lu-DOTA-EB-FAPI 1 radionuclide therapy
        • +2 more
        • Xiamen, China
          The First Affiliated Hospital of Xiamen University
        Nov 3, 2022

        Thyroid Cancer, Thyroid Cancer, Follicular, Papillary Thyroid Cancer Trial in United States (Trametinib, Dabrafenib, PDR001)

        Recruiting
        • Thyroid Cancer
        • +6 more
        • Basking Ridge, New Jersey
        • +6 more
        Jan 19, 2023

        Columnar Cell Variant Thyroid Gland Papillary Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Metastatic

        Active, not recruiting
        • Columnar Cell Variant Thyroid Gland Papillary Carcinoma
        • +25 more
        • Laboratory Biomarker Analysis
        • +3 more
        • Torrance, California
        • +6 more
        Jan 12, 2023

        Thyroid Cancer Trial

        Completed
        • Thyroid Cancer
          • (no location specified)
          Jul 2, 2021

          Thyroid Cancer, Thyroid Cancer, Medullary, Differentiated Thyroid Cancer Trial in Tampa (Lenvatinib, Sorafenib, Cabozantinib)

          Terminated
          Has Results
          • Thyroid Cancer
          • +5 more
          • Tampa, Florida
            H. Lee Moffitt Cancer Center and Research Institute
          Jul 12, 2021

          Differentiated Thyroid Gland Carcinoma, Thyroid Gland Follicular Carcinoma, Thyroid Gland Papillary Carcinoma Trial in Atlanta

          Terminated
          • Differentiated Thyroid Gland Carcinoma
          • +2 more
          • Atlanta, Georgia
            Emory University Hospital/Winship Cancer Institute
          Jun 25, 2021

          Metastatic Thyroid Papillary Carcinoma, Metastatic Thyroid Follicular Carcinoma, Metastatic Thyroid Cancer Trial in Spain

          Recruiting
          • Metastatic Thyroid Papillary Carcinoma
          • +2 more
          • L'Hospitalet de Llobregat, Barcelona, Spain
          • +14 more
          Feb 18, 2022

          Small Cell Lung Cancer, Uveal Melanoma, Ovarian Clear Cell Carcinoma Trial in United States (PLX2853)

          Completed
          • Small Cell Lung Cancer
          • +7 more
          • Scottsdale, Arizona
          • +4 more
          Jul 20, 2022

          Synthetic Thyroid Hormone for Thyroid Cancer Treatment

          Completed
          • Malignant Struma Ovarii
          • +4 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Sep 25, 2020

            Thyroid Tumors Trial in Lexington (Lenalidomide)

            Completed
            Has Results
            • Thyroid Neoplasms
            • Lexington, Kentucky
              University of Kentucky Markey Cancer Center
            May 28, 2020

            Papillary Thyroid Cancer, Follicular Thyroid Cancer, Differentiated Thyroid Cancer Trial in Washington (SU011248, Sutent)

            Completed
            Has Results
            • Papillary Thyroid Cancer
            • +2 more
            • SU011248, Sutent
            • Washington, District of Columbia
              MedStar Washington Hospital Center
            Aug 3, 2020

            Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

            Completed
            • Melanoma
            • +25 more
            • Scottsdale, Arizona
            • +10 more
            Sep 27, 2022

            Refractory Differentiated Thyroid Gland Carcinoma, Refractory Thyroid Gland Follicular Carcinoma, Refractory Thyroid Gland

            Completed
            Has Results
            • Refractory Differentiated Thyroid Gland Carcinoma
            • +4 more
            • Duarte, California
            • +32 more
            Jun 24, 2021

            Retrospective Samples and Prospective Collection of Surplus

            Enrolling by invitation
            • Cancer
              • Seattle, Washington
                Global BioClinical
              Mar 14, 2022

              Gastric Adenocarcinoma Trial (cadonilimab combined +paclitaxel (albumin-bound))

              Not yet recruiting
              • Gastric Adenocarcinoma
              • cadonilimab combined +paclitaxel (albumin-bound)
              • (no location specified)
              Nov 1, 2023

              Patients Undergoing Follicular Lymphoma Clinical Research

              Not yet recruiting
              • Follicular Lymphoma
                • San Francisco, California
                  Power Life Sciences
                Sep 15, 2023

                Pancreatic Ductal Adenocarcinoma Trial in Saint Louis (BMS-813160, Nivolumab, Gemcitabine)

                Active, not recruiting
                Has Results
                • Pancreatic Ductal Adenocarcinoma
                • Saint Louis, Missouri
                  Washington University School of Medicine
                Dec 8, 2022